Insulin Therapy News

• Pumps and Patches: Technology Benefits Youth With Type 1 Diabetes Use of diabetes technology, including insulin pumps and continuous glucose monitors, reduces A1c, DKA, and severe hypoglycemia in those younger than 18.
  Medscape Medical News, March 19, 2021
• AAGP 2021 Cannabinoids May Improve Appetite, Behavior in Dementia Its use for patients with dementia may involve finding a "sweet spot" of improving appetite and sleep while not worsening anxiety or psychosis.
  Medscape Medical News, March 19, 2021
• Less Risk of Hypoglycemia With Long-Acting Insulin in Elderly Long-acting insulin analogs may be a safer option than neutral protamine Hagedorn (NPH, also known as isophane insulin) in elderly patients with type 2 diabetes initiating insulin therapy, according to a large observational study.
  Reuters Health Information, March 01, 2021
• Contrary to Popular Belief, Insulin Can Be Stored Outside Fridge In a study, insulin retained its potency in conditions in which the temperature oscillated between 25 and 37 degrees Celsius (77 to 98.6 Fahrenheit) during a 28-day period of use.
  Medscape Medical News, February 26, 2021
• Medicare Beneficiaries With High Out-of-Pocket Costs May Reduce Insulin Adherence Patients with diabetes who face high out-of-pocket costs under Medicare Part D may buy or use less insulin than they're prescribed, according to a new study.
  Reuters Health Information, February 18, 2021
• PET Predicts Response to Endocrine Therapy in ER+ Breast Cancer Only half the women with ER+ breast cancer who get endocrine therapy respond. Could functional tests and a PET scan identify those women?
  Medscape Medical News, February 15, 2021
• First Cybersecurity Chief of Medical Devices Takes the Reins With concerns rising, the FDA has hired Kevin Fu, PhD, as the first acting director of medical device cybersecurity, a new 1-year position within the Center for Devices and Radiological Health.
  Medscape Medical News, February 10, 2021
• Prostate Cancer Drug Equally Effective in Black and White Men The first randomized clinical trial comparing bicalutamide with enzalutamide in a substantial number of Black patients shows equal results with White patients.
  Medscape Medical News, January 29, 2021
• UK Launch for Most Advanced 'Artificial Pancreas', MiniMed 780G Medtronic launches latest MiniMed 780G hybrid closed-loop insulin delivery system in the UK.
  Medscape Medical News, January 27, 2021
• Endocrine Society Call for Action to Reduce Insulin Costs in US New position statement is issued in year of 100th anniversary of the discovery of insulin, and as a new US presidential administration is set to tackle healthcare.
  Medscape Medical News, January 13, 2021
• Early Insulin Pump Use Tied to Better Outcomes in Kids With Type 1 Diabetes Children with type 1 diabetes who initiate insulin pump use within six months of diagnosis have better outcomes than those who delay initiation until the second or third year after diagnosis, a recent study suggests.
  Reuters Health Information, December 11, 2020
• The 'Wondrous Map': Charting of the Human Genome, 20 Years Later From COVID-19 to prenatal diagnostics and precision medicine, genomics has slowly but surely moved into the clinic, and forever altered medicine. But many new frontiers lie ahead.
  Medscape Medical News, December 11, 2020
• 'Smart' Insulin Pen With CGM First to Launch in Emerging Field InPen with Real-Time Guardian Connect CGM Data brings together Medtronic's technologies as the 'smart pen' landscape expands for patients with diabetes taking multiple daily injections.
  Medscape Medical News, November 17, 2020
• Proposed Medicare Rule Would Expand CGM Coverage The proposed rule would include devices that aren't approved for making treatment decisions.
  Medscape Medical News, November 10, 2020
• Impartial Online Tool IDs 'Best Fit' Devices for Diabetes Patients The new tool helps patients with insulin-treated diabetes and their clinicians identify the best diabetes technology for a patient based on individual needs and preferences.
  Medscape Medical News, November 03, 2020
• Consensus Guidelines Address Inpatient Diabetes Technology The comprehensive document aimed at clinicians, hospitals, and researchers covers use of both continuous glucose monitors and automated insulin dosing systems in the hospital setting.
  Medscape Medical News, October 27, 2020
• It's Complex: Rise in Diabetes Drug Costs in US Is Multifactorial More users, higher insulin cost-per-user, and greater use of newer noninsulin medicines are key, but other factors also play a role.
  Medscape Medical News, October 16, 2020
• Endoscopic Duodenal Resurfacing May Eliminate Need for Insulin in Type 2 Diabetes A single endoscopic duodenal mucosal resurfacing, coupled with a GLP-1 agonist and lifestyle coaching, can eliminate the need for insulin in most patients with type 2 diabetes, according to results of a pilot study.
  Reuters Health Information, October 12, 2020
• US Has Highest Insulin Costs of Any Developed Nation Study conducted for the US government finds America pays an average eight times as much for insulin.
  Medscape Medical News, October 08, 2020
• EASD 2020 Novel Dual-Hormone 'Artificial Pancreas' Is Promising The fully automated dual hormone combination of rapid-acting insulin plus pramlintide, with no meal notification required, produced similar results to Fiasp-alone with meal signaling.
  Medscape Medical News, October 06, 2020